Treg-specific IFNAR-deficient mice exhibit heightened Treg activity, increased expression of activation markers (CD44, Ki-67, ICOS, PD-1), and reduced CD8+ T cell responses, ultimately resulting in impaired tumor control [58]. This evidence concerns the gene CD8A and neoplasm.